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Abstract 1 
Three novel borosilicate bioactive glasses (BBGs) of general formula of 0.05Na2O0.35x 2 
0.20B2O30.40SiO2 (molar ratio, where x = MgO or CaO or SrO) were prepared and used to 3 
investigate the effect of crystallisation on their properties including cytotoxicity. The three post-4 
melt compositions were determined using X-ray fluorescence spectroscopy and crystallisation 5 
events were studied using differential thermal analysis and x-ray diffraction. This information was 6 
used to determine heat treatments to prepare glass-ceramics by controlled crystallisation. X-ray 7 
diffraction analysis and Fourier transform infrared spectroscopy showed that, after higher heat 8 
treatment temperatures (800-900 ºC), borosilicate bioactive glass-ceramics (BBGCs) contained 9 
mainly borate and silicate crystalline phases. Specifically, BBG-Mg, BBG-Ca and BBG-Sr glass-10 
ceramics detected the presence of magnesium silicate-Mg2(SiO3)2 and magnesium borate-Mg2B2O5; 11 
wollastonite-2M-CaSiO3 and calcium borate-Ca(BO2)2; and strontium silicate-SrSiO3 and strontium 12 
borate-Sr2B2O5, respectively. In vitro cytotoxicity tests were performed using the mouse fibroblast 13 
cell line (L929). Glass and glass ceramic at concentrations lower than 50 mg/ml did not exhibit any 14 
level of cytotoxicity when compared with the control. However, quantitative evaluation indicated 15 
that greater cell growth occurred in the presence of materials with crystalline phases. Control of 16 
BBGs crystallisation may therefore be used to influence the biocompatibility of these glass-ceramic 17 
systems. 18 
Keywords: Bioactive glasses, borosilicate, crystallisation, glass-ceramic and cytotoxicity. 19 
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1. Introduction 1 
Bioactive glasses (BGs) and bioactive glass-ceramics (BGCs) have been evaluated for a wide range 2 
of clinical applications related to bone tissue repair and regeneration 1. BGs and BGCs are widely 3 
reported to form a bone-like hydroxyapatite (HA) layer on their surface when placed in a simulated 4 
biological environment 2. This has also been demonstrated to occur in vivo 3. Formation of a bone-5 
like HA layer is a fundamental requirement for the establishment of a strong interfacial bond 6 
between implants and bone 4. Since Hench et al. 2 proposed the CaO: SiO2: Na2O: P2O5 system in 7 
1969, 45S5 bioglass (or Bioglass®) has become the gold standard for this type of material. 8 
However, slow degradation rate is a major disadvantage of the silicate based BG, which makes it 9 
difficult to match the degradation rate of the BG scaffolds with the rate of new tissue formation 5, 6. 10 
Moreover, some studies with silicate glasses report slow conversion rate to a bone-like HA and 11 
often this conversion remains incomplete. Therefore unconverted glass containing SiO2 could 12 
remain in human body long after its implantation, raising uncertainty regarding the long-term 13 
effects of SiO2 in vivo 7, 8. 14 
The addition of boron oxide to the glass network is one approach that has the potential to overcome 15 
the limitations identified above by modifying dissolution rates as well as other properties including 16 
tissue bonding 9. The incorporation of boron in a silicate glass matrix involves lower melting 17 
temperatures, with an increased bio-degradation and increased conversion to HA 8, 10, 11. 18 
Furthermore, boron is reported to be beneficial for bone healing and its controlled release stimulates 19 
bone formation and maintenance. Frequently, it has been associated with the increase in bone 20 
resistance to fractures 12-14. Thereby, borosilicate bioactive glasses (BBGs) composition may be 21 
used to achieve a more controlled release of specific component ions in order to trigger a range of 22 
biological responses 15. Control of the surface reactions and therefore of the biodegradation and 23 
bioactivity of implanted materials can be achieved by varying the chemical nature and/or 24 
 4 
concentration of the BBGs constituents. For instance, Ciceo Lucacel et al. 16 have used the calcium 1 
BBGs doped with silver (Ag+) to better control Ag+ antibacterial properties. Xu et al. 6 have also 2 
proposed a sol±gel-derived calcium BBGs system for reinforcing glass-ceramic porous biomaterials 3 
and accurately control theirs biodegradability. In another study by Wang et al. 17, evaluating the of 4 
osteogenic properties of BBGs doped with Zinc (Zn2+) these BBGs significantly enhanced bone 5 
regeneration in bone defects when implanted into the rats in vivo. Baiano et al. 18 used bioactive 6 
glass-based trabecular coating for the development of a novel prosthetic acetabular cup to have an 7 
improved in vivo interfacial bond with bone. 8 
While studies have been demonstrating the ability of BBGs to better control degradation, thus 9 
increasing the beneficial properties of ions release, there are still concerns regarding toxicity when 10 
those glasses are implanted 19, 20. There are several metal ions that at higher concentrations are 11 
extremely toxic. In particular, boron release has been associated with cell growth inhibition for 12 
concentrations greater then 2.5 mM and also causes cytotoxicity due to release of (BO3)3- into the 13 
medium 12, 19, 20. Several cellular studies investigated the cytotoxicity of BGs and reported inhibition 14 
of cell viability and proliferation for high doses of ions in culture 21, 22. For instance, Santocildes-15 
Romero et al. 23 have showed an increase of the cytotoxic effect of BGs dissolution by increasing 16 
the amount of glass powders used and the level of strontium substitution added to the glass 17 
composition. Moreover, specific component ions released in a controlled rate may stimulate 18 
differently cells. Metallic ions such as magnesium (Mg2+), calcium (Ca2+) or strontium (Sr2+) can 19 
stimulate bone cell proliferation, differentiation and extracellular matrix mineralisation, as well as 20 
increase the production rate of HA and bone 21, 22, 24-26. For instance, Mg2+ in commonly related with 21 
cells adhesion and stability 24, while Ca2+ 25and Sr2+ 26 are generally associated to apatite formation 22 
process and cells differentiation and mineralisation. Moreover, Sr2+ has been successfully studied 23 
for the treatment of osteoporosis21.  24 
Various studies have been reported concerning the use of heat treatments in order to induce 25 
crystallisation in BGs to promote changes in their physico-chemical properties 27-31. For instance, 26 
 5 
Rao et al. 32 have observed improvements in the dielectric constant and less dielectric loss of 1 
sodium borosilicate glasses (SiO2 ±B2O3±Na2O system) with increase in the duration of the heat 2 
treatment. Daguano et al. 27 developed and characterised BGs and BGCs from the CaO-P2O5-SiO2-3 
MgO system, using different degrees of crystallinity. They showed that partial crystallisation 4 
improved mechanical properties by phase transformation, which modified the microstructure of the 5 
base glassy material. Therefore, after studying the thermal profile of BGs, appropriated heat 6 
treatment cycle with a controlled temperature increase could be applied to promote the re-7 
arrangement of the glass structures generating a well-ordered and crystalline structure. The 8 
properties of the formed glass-ceramics are mostly influenced by the characteristics of the finely 9 
dispersed crystalline and the residual glassy phases, which can be controlled by the composition of 10 
the base glass. However, few authors have reported that the formation of new crystalline phases 11 
provoked the modification of toxic effects induced by the glasses in cells 27, 30. Specially, Hurrell-12 
Gillingham et al. 30 investigated the effects of devitrification of glass-ionomer cements (GICs) from 13 
SiO2-Al2O3-P2O5-CaO-CaF2 system on glass-ceramic formation and in vitro biocompatibility. They 14 
demonstrated that crystallisation might be used to improve the in vitro biocompatibility of GICs. 15 
Also Freeman at al. 33 studied the response to implantation of apatite glass-ceramics. They 16 
demonstrated that crystallisation significantly improved the bone tissue response.  17 
It seems likely that devitrification of glasses represents a route to modify and study their properties 18 
including biocompatibility. However, few attempts to modify the biocompatibility of a medical 19 
grade glasses using this approach have been reported 30, 33. This study aimed to firstly synthesise 20 
and characterise the thermal and chemical properties of three novel substituted BBGs. The 21 
incorporation of different ions (i.e. Mg2+, Ca2+ and Sr2+) in BBGs lies on the fact that specific 22 
effects can be used to achieve different human cell behaviour by the release of ionic dissolution 23 
products. Secondly, we aimed to investigate the effect of BBGs crystallisation on their cytotoxic 24 
effects, providing a method for the improvement of bioactive borosilicate glass-ceramics cellular 25 
properties. 26 
 6 
2. Materials and methods 1 
2.1. Materials 2 
All chemical compounds used for melt-quenched synthesis were reagent grade: di-boron trioxide 3 
(Alfa Aesar, Germany), calcium carbonate (Sigma-Aldrich, Portugal), sodium bicarbonate (Sigma-4 
Aldrich, Australia), silica gel 60M (Macherey-Nagel, Germany), magnesium oxide (Sigma-Aldrich, 5 
Portugal) and strontium carbonate (Sigma-Aldrich, Australia).  6 
2.2. Glass synthesis and preparation 7 
The novel BBGs of general formula 0.05Na2O  xMgO  yCaO  (0.35-x-y)SrO  0.20B2O3  8 
0.40SiO2 (molar ratio, where x, y = 0.35 or 0.00, and x y) were synthesised by melt quenching. 9 
The appropriate amounts of SiO2, B2O3, NaHCO3, and CaCO3 or MgO or SrCO3 were accurately 10 
mixed with ethanol (Sigma, Portugal) in a porcelain pestle and mortar, fully dried overnight and 11 
transfer to a platinum crucible. The batch was heated to 1450 Û&LQDLUIRUKRXUDQGVXEVHTXHQWO\12 
the melt was quickly poured in a water bath at 4 Û&WRIRUPa glass frit. The glass frit was ground 13 
into an Agate mortar (RETSCH, Germany) to obtain microparticles and then, sieved for a size 14 
VPDOOHUWKDQȝP 15 
2.3. Characterisation 16 
2.3.1. X-ray fluorescence (XRF) 17 
The X-ray fluorescence spectroscopy was used to confirm the glass composition (Philips PW2400 18 
X-ray fluorescence spectrometer). Samples were prepared by fusing powdered glass with a known 19 
quantity of boron and a flux producing a glass-like bead. After which, they were irradiated with 20 
high-energy primary X-ray photons. All the samples were run in triplicate and the percentage (w/w) 21 
of the oxides present were determined. Afterwards, molar percentage was calculated for all the 22 
samples. 23 
 7 
2.3.2. Differential thermal analysis (DTA) and heat treatment 1 
The mid point of glass transition (Tg), and crystallisation (Tc) temperatures were determined by 2 
differential thermal analysis (Perkin-Elmar DTA7 running Pyris thermal analysis software in Unix) 3 
at a heating rate of 10 ºC min-1 from 50 to 1300 ºC.  4 
In accordance with DTA data, crystallised glass was prepared for each sample. Briefly, fast-5 
quenched particles of the glass samples were heat-treated with a heating rate of 10 ºC min-1 and 6 
held for 120 min at each temperature (Tg, Tc1, Tc2 and Tc3) before cooling to room temperature.  7 
2.3.3. X-ray diffraction analysis (XRD) and attenuated total reflection Fourier transform 8 
infrared (ATR-FTIR) spectroscopy 9 
The glasses were analysed before and after each heat treatment by X-ray diffraction analysis (XRD) 10 
and attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). A STOE 11 
STADI P X-ray diffractometer was used to identify the crystalline phases. The glass samples were 12 
place in aluminium holders and analysed by Cu radiation of wavelength 1.5406 Å at 40 kV and 40 13 
mA with a step size of 0.LQDUDQJHRIșYDOXHVIURPWRDWDVFDQQLQJVSHHGRIVVWHS14 
The crystalline patterns were identified by the use of the cards listed in the Joint Commission on 15 
Powder Diffraction Standards (JCPDS). The ATR-FTIR spectra were obtained using a Perkin-16 
Elmer GX instrument in the range of 4000-550 cmí1 (resolution 4 cmí1) for the identification of the 17 
chemical bonds present in the glass or glass-ceramic structures. 18 
2.4. In vitro cytotoxicity 19 
The in vitro cytotoxicity study was design following the international guidelines ISO 10993-5:2009 20 
34
, using immortalised mouse lung fibroblast-like cell line (L929, Rockville, MD) in indirect contact 21 
with glass powders for 3 days. The samples were sterilised in an oven (Gallenkamp Hot Box, 22 
England) at 160 °C for 120 min. After sterilisation, the glasses were added to Dulbecco's modified 23 
Eagle medium (DMEM, Sigma-Aldrich, UK) solution at a concentration of 0.2 g/mL and incubated 24 
 8 
for 24 h at 37 °C. After incubation, the glass-conditioned medium was removed and filtered through 1 
a 0.2 µm membrane.  2 
The L929 cells were expanded in DMEM supplemented with 10 % (v/v) fetal calf serum (Sigma-3 
Aldrich, UK), penicillin (100 U/mL, Sigma-Aldrich, UK DQG VWUHSWRP\FLQ  ȝJP/, Sigma-4 
Aldrich, UK), and non-essential amino acids (NEAA, Sigma-Aldrich, UK). The L929 cells were 5 
cultured at 37 °C in an atmosphere of 5 % CO2. Confluent L929 cells at passages between 15 and 6 
19 were harvested and seeded into 48-well culture plates (growth area 0.95 cm2) at a density of 7 
2×104 cells/well. After a 24 h culture period the culture media was discarded and replaced with 0.5 8 
cm3 of serially diluted, glass-conditioned medium (at a final concentrations of 100, 50, 25, 10, and 5 9 
%). L929 cells cultured in the absence of glass particles, was used as negative control and 45S5 10 
bioglass- conditioned medium as positive control. After 1 and 3 days time of culturing, the culture 11 
medium was removed and the viability and DNA content of the cultures were analysed using 12 
PrestoBlue® and Picogreen® assays respectively. 13 
Cell viability assessment: The PrestoBlue® reagent (Fisher Scientific, UK) is a resazurin-based 14 
non-fluorescent solution that is reduced to fluorescent resorufin by viable cells.  The assay was 15 
SHUIRUPHGDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV,QEULHIWKHPrestoBlue® reagent was added 16 
to a final concentration of 10% to the cell cultures and the cultures incubated for 1 h at 37oC. 200 µl 17 
samples of the culture medium were removed and placed in 96-well plates and the resorufin 18 
fluorescence quantified spectrophotometrically using a plate reader (Tecan Infinite M200). The 19 
fluorescence was determined at an excitation wavelength of 560 nm and emission wavelength of 20 
590 nm. The cell viabilities are normalised as % of the metabolic activity of the control cell 21 
cultures. 22 
DNA measurement: The PicoGreen® dsDNA reagent (Invitrogen, USA) is an ultrasensitive 23 
fluorescent nucleic acid dye for quantification of double-stranded DNA (dsDNA) in solution. This 24 
assay enables measurement of cell proliferation. After each culturing period, the cell monolayers 25 
 9 
were washed with PBS and then incubated at 37 ºC for 3 h followed by freezing step at -80 ºC for at 1 
least over night in ultra-pure water (1 mL) to ensure cell lysis. The assay was performed according 2 
WRWKHPDQXIDFWXUHU¶VSURWRFRO$QGWKH fluorescence was determined at an excitation wavelength 3 
of 485 nm and emission wavelength of 528 nm. The DNA values were normalised to those of the 4 
control cultures 5 
Morphological evaluation of cell cultures: After each culturing period the cell monolayers were 6 
washed with PBS and fixed with 4 % formalin solution (0.5 mL) for 15 min at room temperature 7 
(RT). The cell layers were then washed with PBS, containing 0.2 % Triton X, for 2 min. After the 8 
fixation and permeation steps, the cell monolayers were washed again with PBS and stained with 9 
4,6-diamidino-2-phenyindole dilactate (1:1000 DAPI, Sigma, UK) for 2 min at RT, and phalloidin-10 
tetramethylrhodamine B isothiocyanate (Sigma, UK) for 1 h at RT. Finally, the cells were washed 11 
and observed using an Axioplan 2 imaging fluorescent microscope with a digital camera QIC AM 12 
12-bit (Zeiss, UK).  13 
2.5. Statistical analysis 14 
Experiments were run at least in triplicate for each sample. All data were expressed as mean ± 15 
standard deviation (SD). Statistical analysis was determined by using Graphpad Prim® software, 16 
version 6.0. The normality of the data distribution was monitored by Shapiro-Wilk test (p < 0.05). 17 
Some of the datasets were not considered to have a normal distribution, requiring a non-parametric 18 
statistical evaluation. In this context, Kruskal-Wallis test (p < 0.05) was applied to all dataset, 19 
IROORZHGE\D'XQQ¶V0XOWLSOH&RPSDULVRQWHVW 20 
 10 
3. Results and Discussion 1 
3.1. Glass characterisation 2 
3.1.1. X-ray fluorescence 3 
The X-ray fluorescence data, presented in Table 1, confirmed that the experimental compositions of 4 
bioactive borosilicate glasses obtained by melt-quench method were close to the expected 5 
theoretical composition, indicating that the glass network structure was formed as aimed. However, 6 
the slight differences between theoretical and XRF data may have been caused by the high volatility 7 
of alkali-borate compounds during melting process 35. 8 
Table 1 - X-ray fluorescence spectrometry estimation of elemental concentration (mol %) of BBGs. 9 
BBG-Mg, -Ca and -Sr glasses (* varies with the specific ion for each glass). All analysis were 10 
performed in triplicate and standard deviation < 0.05. 11 
Samples / composition Si (mol %) B (mol %) Na (mol %) Ions* (mol %) 
BBG-Mg 37.6 (40) 34.8 (40) 10.4 (10) 39.7 (35) 
BBG-Ca 36.9 (40) 43.8 (40) 10.4 (10) 36.0 (35) 
BBG-Sr 37.5 (40) 41.4 (40) 10.4 (10) 36.7 (35) 
3.1.2. Differential thermal analysis 12 
The DTA was used to study the phase transformation temperatures of the BBGs in order to 13 
determine the heat treatment schedule. DTA patterns from all BBGs are presented in Figure 1a. For 14 
BBG-Mg and BBG-Sr along with the mid point of glass transition temperature (Tg - endothermic 15 
peak), two crystallisation temperatures (Tc - exothermic peaks) were found; while BBG-Ca glasses 16 
presented a Tg and one exothermic (Tc1) peak followed by a doublet exothermic peak (Tc2 and Tc3). 17 
 11 
The Tg and Tc used for the different glass compositions are listed in Figure 1b. The BBGs revealed 1 
crystallisation temperatures within the range of temperatures of 700 to 900 °C with two phases 2 
frequently related with borate and silicate crystal phases 15. The endothermic peaks are related to 3 
the molecular re-arrangement in glass structure preceding and during glass crystallisation, a process 4 
known for crystal nucleation and growth 15, 29. In order to induce crystal nucleus formation in the 5 
glass structure, BBGs were kept for 2 hours at Tg and subsequently for 2 hours at each Tc. Each 6 
well-defined exothermic peak may result in the formation of a different crystalline phases 28. For 7 
each BBGs different heat treatment schedules were applied according to the endo- and exothermic 8 
peak temperatures reported in Figure 1b. 9 
 10 
Figure 1 - (a) DTA patterns of BBG-Mg, BBG-Ca and BBG-Sr glasses. Tg ± mid point of glass 11 
transition temperature and Tc ± crystallization temperature. (b) The mid point of glass transition 12 
 12 
temperature and crystallization temperatures for the BBGs (BBG-Mg, -Ca and -Sr glasses) 1 
determined by DTA analysis (Tg ± mid point of glass transition temperature and Tc ± crystallization 2 
temperature). 3 
3.1.3. X-ray diffraction and attenuated total reflection Fourier transform infrared 4 
The XRD analysis was performed in order to study the crystallinity of the glasses before and after 5 
heat treatments and the respective phases formed (Table 2). Figure 2a, 2b and 2c shows the phase 6 
evolution XRD patterns of BBG-Mg, -Ca and -Sr glasses, respectively, from amorphous to 7 
crystalline phase after the different heat treatment schedules. Heat treatment schedule at Tg were 8 
performed and exhibit no significant difference in respect with the as quenched XRD patterns. 9 
The XRD patterns of BBG-Mg glass after the first crystallisation heat treatment (BBG-Mg_Tc1) 10 
showed a predominantly amorphous phase with weak diffraction peaks, which can be assigned to 11 
silicon oxide (SiO2, JCPDS Card No. 11-252). After Tc2 heat treatment (BBG-Mg_Tc2) two 12 
predominant crystalline phases of magnesium silicate (Mg2(SiO3)2, JCPDS Card No. 86-433) and 13 
magnesium borate (Mg2B2O5, JCPDS Card No. 73-2232) were observed. 14 
In the case of XRD patterns of BBG-Ca glass after the first crystallisation heat treatment (BBG-15 
Ca_Tc1) it was observed a predominantly amorphous phase with some weak diffraction peaks, 16 
which can be attributed either to calcium silicate (CaSiO3, JCPDS Card No. 76-186) and/or calcium 17 
borate (Ca(BO2)2, JCPDS Card No. 31-155), indicating that after Tc1 crystallisation started to occur. 18 
After the second heat treatment (BBG-Ca_Tc2) there is the formation of two predominant crystalline 19 
phases, calcium silicate, commonly referred as wollastonite-2M and calcium borate. After the Tc3 20 
heat treatment (BBG-Ca_Tc3) the diffraction patterns are comparable to the previous heat treatment 21 
patterns (Tc2), which indicates that no detectable amount of different crystalline phase is forming. 22 
For the BBG-Sr glass, after the first crystallisation heat treatment (BBG-Sr_Tc1) it was observed a 23 
predominant amorphous phase of the glass and a weak diffraction peak, in which the weak peaks 24 
 13 
can be attributed either to strontium silicate (SrSiO3, JCPDS Card No. 87-474) and/or strontium 1 
borate (Sr2B2O5, JCPDS Card No. 19-1268), suggesting that the formation of crystalline phases 2 
starts after the first crystallisation heat treatment. After the second heat treatment (BBG-Sr_Tc2) 3 
there were formed two crystalline phases of strontium silicate and strontium borate. 4 
Finally, XRD data showed that for all BBGs after heat treatment with lower crystallisation 5 
temperatures (Tc1) there was predominantly amorphous with only a small amount crystals 6 
formation. However after latter heat treatments (Tc2 and Tc3) occurred the formation of crystalline 7 
phases resulting in new silicate and borate glass-ceramics. 8 
Table 2 - Crystalline phases of BBG-Mg, -Ca and -Sr glasses obtained after heat treatments 9 
Heat treatment Heat temperature conditions Crystalline phases 
BBG-Mg_Tc1 623 °C / 2h + 726 °C / 2 h Glass and SiO2 
BBG-Mg_Tc2 623 °C / 2 h + 856 °C / 2 h Mg2(SiO3)2; Mg2B2O5 
BBG-Ca_Tc1 622 °C / 2 h + 716 °C / 2 h Glass and Ca(BO2)2 
BBG-Ca_Tc2 622 °C / 2 h + 827 °C / 2 h CaSiO3; Ca(BO2)2 
BBG-Ca_Tc3 622 °C / 2 h + 897 °C / 2 h CaSiO3; Ca(BO2)2 
BBG-Sr_Tc1 606 °C / 2 h + 697 °C / 2 h Glass and SrSiO3; Sr2B2O5 
BBG-Sr_Tc2 606 °C / 2 h + 862 °C / 2 h SrSiO3; Sr2B2O5 
 14 
 1 
 15 
Figure 2 - X-ray diffraction patterns of phase evolution over increasing crystallisation temperatures 1 
for BBG-Mg (a), -Ca (b), -Sr (c) glasses (BBG-ion - before heat treatment, Tc1 - after first heat 2 
treatment, Tc2 - after second heat treatment, Tc3 - after third heat treatment). 3 
The ATR-FTIR analysis was performed to evaluate the possible changes of vibrational spectra after 4 
the heat treatments, because they can induce a process of structural grouping re-arrangements, 5 
implying important modifications in the properties of the glasses 30, 36. ATR-FTIR spectra of BBG-6 
Mg, -Ca, -Sr glasses and glass-ceramics are presented in Figure 3a, 3b and 3c, respectively. ATR-7 
FTIR spectra of all BBGs consist of dominant broad bands from 740-585 and 1210-740 cm-1 8 
generally attributed to B-O stretching of tetrahedral [BO4] units, and 1550-1260 cm-1, which are 9 
attributed to B-O stretching of trigonal [BO3] unit 10, 36. On the other hand the same broad bands 10 
from 740-585 and 1240-740 cm-1 can be also assigned to Si-O-Si symmetric and asymmetric 11 
stretching, respectively 37-39. The presence of these intense bands indicates the coexistence of 12 
silicate and borate bonds, which supports the presence of borosilicate network structure in the 13 
amorphous phase. There are two additional less intense bands ranging from 3000 to 2800 and 3750 14 
to 3500 cm-1 in all spectra before and after heat treatment, which can be associated with water 15 
content. The bands in the range 3000 to 2800 cm-1 have origin in hydrogen bonds and peaks from 16 
3750 to 3500 cm-1 are due to OH- groups 36, 40, 41. Furthermore, there are no significant differences 17 
comparing ATR-FTIR spectra of BBGs before and after Tc1 heat treatment (comparing BBG-ion 18 
with Tc1 of Figure 3a, 3b and 3c). This fact suggests that there was no formation of detectable 19 
crystalline phases. However, for the latter heat treatments (Tc2 and Tc3) all BBGs showed a splitting 20 
of the intense broad bands in several sharp peaks. The splitting of the broad bands might indicate 21 
structural grouping re-arrangements (e.g. 1210-740 cm-1 broad band is splitting in 4 different peaks 22 
for BBG-Mg glass-ceramic; Figure 3a). Thus, temperatures higher than 800 °C indeed affected the 23 
glass network by rearranging the borosilicate structure. Moreover ATR-FTIR spectra of BBG-Ca 24 
glass-ceramics (after Tc2 and Tc3 heat treatment ± Figure 3b) did not show significant differences. 25 
This analysis agrees with XRD data, indicating that the crystallisation temperatures of the double 26 
 16 
exothermic peak found by DTA (Figure 1) did not introduce an evident different molecular re-1 
arrangement in glass structure and thereby theirs ATR-FTIR spectra will be analysed as one. The 2 
correspondent assignments for sharp peaks formed after the latter heat treatments (Tc2 and Tc3) are 3 
presented in Figure 3d, from where vibrational peaks ranging from 636-595 and 1270-1010 cm-1 4 
can be attributed to the formation of Si-O-Si bonds and Si-O-Si asymmetric stretching, respectively 5 
37, 39, 42
. On the other hand peaks ranging from 735-680 and 1010-935 cm-1 can be assigned to 6 
bending of B2-O bonds in the borate glassy network and B2-O bond of tetrahedral [BO4] 36, 43, 44. 7 
Finally, peaks ranging from 680-645 and 1195-1010 cm-1 can be attributed to the formation of Si-8 
O-B bonds 10, 36, 45. These assigned peaks confirmed the existence of new silicon and boron units at 9 
the structure network as shown by XRD data. Of highlighting are the peaks found from 915-830 10 
and 955-870 cm-1 that can be assigned to the formation of Si±O±Ion and B-O-Ion bonds. That 11 
indicates the presence of silicate and borate structures bonding metallic ions, which is in agreement 12 
with the formation of metal silicates and borates found by XRD analysis 10, 42, 43. 13 
The ATR-FTIR analysis showed that for the latter heat treatments there are peaks that can be 14 
attributed to B-O-B and Si-O-Si bonds formation. The presence of those bonds supports the 15 
formation of silicate and borate crystalline phases previously indicated by XRD data. Also, peaks in 16 
the region of 950 to 850 cm-1 that are related with the formation either of Ion-O-Si and Ion-O-B, 17 
strongly supports the presence of crystalline phases metal silicate and borate. 18 
 17 
 1 
Figure 3 - ATR-FTIR spectra of BBG-Mg (a), -Ca (b) and -Sr (c) glasses (BBG-ion - before heat 2 
treatment, Tc1 - after first heat treatment, Tc2 - after second heat treatment, Tc3 - after third heat 3 
treatment). The numbers are referred to the type of bond found: 1 and 8 ± Si-O-Si; 2 and 7 ± Si-O-4 
B; 3 and 6 ± B-O-B; 4 ± Si-O-Ion; 5 ± B-O-Ion. (d) ATR-FTIR band assignments. 5 
3.2. In vitro cytotoxicity 6 
The cytotoxicity studies were designed to evaluate whether the degradation or dissolution of glasses 7 
and glass-ceramics affected the viability and proliferation of mouse lung fibroblast-like cells 8 
(L929). The experimental design was based on the international guidelines of ISO 10993-5:2009 9 
with some adjustments as described in the methods section 34. Each glass and glass-ceramic sample 10 
was pre-incubated in DMEM to give a glass-conditioned media that were added to the cell cultures 11 
for 1 and 3 days.  12 
 18 
The PrestoBlue® viability data (Figure 4) showed that L929 cells in the presence either of glass- or 1 
glass-ceramic-conditioned medium exhibited a metabolic activity higher than 50% for 2 
concentrations lower than 50 mg/mL. In the case of BBG-Mg glass and glass-ceramics even after 3 3 
days of culture, the cells displayed good metabolic activity for media conditioned by concentrations 4 
of 50 mg/mL (e.g.: for BBG-Mg_ Tc2 at 50 mg/mL concentration, cells present 74 % of metabolic 5 
activity). However, all BBGs before and after heat treatment showed far higher metabolic activity 6 
than the commercial 45S5 bioglass (e.g.: after 3 days of culture with 45S5 bioglass-conditioned 7 
media, L929 cells showed only 1% of the metabolic activity observed in the control cultures). 8 
Figure 5 exhibits the DNA measurements of L929 culture normalized to the control cultures 9 
incubated in culture medium only. For all BBGs, before and after heat treatment, concentrations 10 
below 50 mg/mL showed DNA levels indicating cell proliferation rates close to 100%, meaning that 11 
the conditioned medium was not affecting cell proliferation. Similarly to the results observed in the 12 
cell viability assays, BBG-Mg glass or glass-ceramics exhibited less cytotoxic effects than BBG-Ca 13 
and -Sr glasses and glass-ceramics. Higher proliferation rates were observed with the media 14 
conditioned with BBG-Mg than for the BBG-Ca or BBG-Sr-conditioned media (Figure 5). 15 
Furthermore, culture medium conditioned by 45S5 bioglass was found to be significantly more 16 
cytotoxic than culture medium conditioned with BBG glasses and glass-ceramics. Crystallisation of 17 
the glasses was found to have no significant effect on cellular behaviour at day 1 however at day 3, 18 
different cellular behaviour profiles were observed at all the concentrations tested. Specifically, for 19 
the BBG-Mg glasses, an increase in cytotoxicity was detected for the first heat-treated glass-20 
ceramics (Tc1), which could be related to the formation of SiO2 during the heat treatment. The 21 
formation of SiO2 molecules reduces the amount of silicate in the dominant amorphous phase, 22 
which may increase the ratio of borate in the amorphous glass matrix. The borate-rich amorphous 23 
phase has a faster degradation rate 15, increasing the quantity of ions in solution as well as the pH (~ 24 
8.0-9.0) 46. On the other hand, the BBG-Mg glass-ceramics formed after the second heat treatment 25 
(Tc2) showed a reduction in cytotoxic, which may have been due to the formation of two different 26 
 19 
crystalline phases (magnesium silicate and magnesium borate) so reducing the availability of ions 1 
contained largely within the stable crystalline phases 27, 30. 2 
The glass-ceramics produced from heat-treated BBG-Ca and -Sr glasses also showed different 3 
cellular behaviour from the parent glasses. A reduction in cytotoxicity was found for glass-ceramics 4 
formed after the first heat treatment (Tc1) and an increase in cytotoxicity with further heat 5 
treatments (Tc2 and Tc3). These results may be explained by the formation of different crystalline 6 
phases with higher availability for ion release, which may have increased the pH and can be directly 7 
observed by colour changes in medium culture 30. The pH of the non-conditioned and conditioned 8 
media was measured and found to range from 8.0 to 8.5 for all BBG glasses and glass ceramics. 9 
The pH of conditioned media from 45S5 bioglass ranged between 8.5 and 9. While the addition of 10 
boron to glass matrix is associated with bone healing and formation as well higher conversion rates 11 
to HA 6, 12; the cytotoxic evaluation demonstrated that it is possible to modify the cytotoxic effects 12 
of BBGs by a controlled crystallisation of the constituent glasses. Together, these features make 13 
BBGs suitable candidates for bone tissue engineering application. 14 
 20 
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Figure 4 - The cell viability of L929 cells after 1 and 3 days of culture with conditioned medium 2 
from BBG-Mg, -Ca and -Sr glass and glass-ceramics. (a, c and e ± 1 day of culture, b, d and f - 3 3 
days of culture). 4 
 21 
 1 
Figure 5 - The proliferation of L929 cells in contact with BBG-Mg, -Ca and -Sr glass and glass-2 
ceramic-conditioned media after 1 and 3 days of culture (a, c and 3 - after 1 day of culture, b, d and 3 
f - after 3 days of culture). 4 
 22 
After 3 days of culture, morphologic assessment of L929 cells (Figure 6) revealed a concentration 1 
dependent behaviour of the BBG-Mg-, BBG-Ca- and BBGCs- conditioned media. Where of 10 2 
mg/mL of BBG-Mg-, BBG-Ca-, BBG-Sr- or BBGCs were used to prepare the conditioned media, 3 
the cells, showed a characteristic fibroblast morphology with the formation of actin filaments that 4 
was similar to that of the control cultures in the absence of glass-conditioned media. Use of 50 5 
mg/mL of BBG-Mg-, BBG-Ca- and BBG-Sr- and BBGCs to prepare the conditioned media, 6 
resulted in fewer cells with a classical elongated fibroblastic and a greater proportion exhibiting a 7 
more rounded morphology. Use of BBG-Mg-, BBG-Ca-, BBG-Sr- or BBGCs concentrations of 200 8 
mg/mL gave conditioned media in which only a few rounded L929 cells could be observed after 3 9 
days. These results are in agreement with cell viability and cell proliferation data (Figure 4 and 5) 10 
supporting a concentration dependence cytotoxic effect. In the case of the commercial 45S5 11 
bioglass cultures, for concentrations higher than 10 mg/mL the in the conditioned media no live 12 
cells were observed after 3 days of culture. At lower 45S5 bioglass concentrations (10 mg/ml), 13 
culture of L929 cells in the 45S5 bioglass-conditioned media resulted in the cells having a 14 
fibroblastic morphology similar to the control cell cultures. As showed by the viability and the 15 
DNA assays, crystallisation of the glasses was found to have a positive or negative effect on cellular 16 
morphology at day 3 of culture. Especially for a concentration of 50 mg/ml, it was observed that the 17 
less toxic samples (i.e. BBG-Mg_Tc2, BBG-Ca_Tc1 and BBG-Sr_Tc1) presented higher number of 18 
cells with a classical elongated fibroblastic morphology. This is consistent with the typical lower 19 
solubility of the ceramic phases when compared to the glassy ones, limiting the release of ionic 20 
components from the BBGCs and maintaining them at non-cytotoxic concentrations in the culture 21 
medium. 22 
Specifically, for the BBG-Mg glasses, an increase in cytotoxicity was detected for the first heat-23 
treated glass-ceramics (Tc1), which could be related to the formation of SiO2 during the heat 24 
treatment. The formation of SiO2 molecules reduces the amount of silicate in the dominant 25 
amorphous phase, which may increase the ratio of borate in the amorphous glass matrix. The 26 
 23 
borate-rich amorphous phase has a faster degradation rate 15, increasing the quantity of ions in 1 
solution as well as the pH (~ 8.0-9.0) 46. On the other hand, the BBG-Mg glass-ceramics formed 2 
after the second heat treatment (Tc2) showed a reduction in cytotoxic, which may have been due to 3 
the formation of two different crystalline phases (magnesium silicate and magnesium borate) so 4 
reducing the availability of ions contained largely within the stable crystalline phases 27, 30. 5 
The glass-ceramics produced from heat-treated BBG-Ca and -Sr glasses also showed different 6 
cellular behaviour from the parent glasses. A reduction in cytotoxicity was found for glass-ceramics 7 
formed after the first heat treatment (Tc1) and an increase in cytotoxicity with further heat 8 
treatments (Tc2 and Tc3). These results may be explained by the formation of different crystalline 9 
phases with higher availability for ion release, which may have increased the pH and can be directly 10 
observed by colour changes in the culture medium 30. The pH of the non-conditioned and 11 
conditioned media was measured and found to range from 8.0 to 8.5 for all BBG glasses and glass 12 
ceramics. The pH of conditioned media from 45S5 bioglass ranged between 8.5 and 9.0. 13 
 14 
 24 
 1 
 25 
Figure 6 ± Fluorescence microscopy of L929 cells morphology after 3 days incubation with BBGs 1 
or BBGCs -conditioned media. Conditioned media were prepared with 10 mg/ml, 50 mg/ml or 200 2 
mg/ml BBG glass or BBGCs. Cells cultured with non-conditioned medium was used as negative 3 
control and 45S5 bioglass conditioned media was used as positive control (The blue colour (DAPI 4 
staining) shows the nucleus of cells; Green colour (phalloidin staining) shows the actin filaments). 5 
4. Conclusions 6 
Three novel amorphous BBGs with different glass modifiers have been successfully synthesised by 7 
the melt quench technique. The DTA analysis allowed the identification of two or more exothermic 8 
peaks indicative of crystallisation. However, after a controlled heat treatment at these temperatures, 9 
XRD and ATR-FTIR data indicated that only the samples that were treated at the higher 10 
crystallisation temperatures produced significant crystalline phase(s). Also, different crystalline 11 
phases were formed for the different substituted BBGs. Specifically for, BBG-Mg, BBG-Ca and 12 
BBG-Sr glass-ceramics was detected the presence of magnesium silicate-Mg2(SiO3)2 and 13 
magnesium borate-Mg2B2O5; wollastonite-2M-CaSiO3 and calcium borate-Ca(BO2)2; and strontium 14 
silicate-SrSiO3 and strontium borate-Sr2B2O5, respectively. To our knowledge, this is the first time 15 
it is demonstrated that controlled crystallisation of BBGs might produce glass-ceramics with less 16 
cytotoxic effects on cells. Moreover, neither BBGs nor BBGCs induced a cytotoxic effect on cells 17 
at concentrations lower than 50 mg/mL and they exhibited less cytotoxicity compared to 45S5 18 
bioglass at all concentrations used. Finally, interaction of BBGs with cells in a biological 19 
environment is a complex process that is continuously under study from the scientific and medical 20 
device communities. However, the great biodegradable properties of BBGs combined with the fact 21 
that partial or total crystallisation permits cytotoxicity reduction. The BBGs can be used to achieve 22 
medical-grade material for development of new generation bone tissue engineered implants. 23 
 26 
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With this research the effect of crystallisation on the properties of borosilicate bioactive glasses 
(BBGs) and their suitability as biomaterials was evaluated. By in vitro cytotoxicity assay we 
demonstrated that the crystallisation of the BBGs reduced their cytotoxicity to L929 cell line, 
providing a method for the improvement of the biocompatibility of bioactive borosilicate glass-
ceramics. 
